Capricor Therapeutics

Capricor Therapeutics

Capricor Therapeutics

(Nasdaq:CAPR), a biotechnology company focused on the discovery, development & commercialization of first-in-class therapeutics for the treatment of diseases.
Founded
2005
Raised
$4.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,200,000
Grant - 2016
National Institutes of Health
Team Size
1–10
Employees
$4,200,000 Grant
socalTECH.com

Capricor Therapeutics Gets $4.2M Grant

Health